TA155 Macular degeneration (age-related) - ranibizumab and pegaptanib: understanding NICE guidance (MS Word format)

The summary of the key recommendations of the technology appraisal on Macular degeneration (age-related) - ranibizumab and pegaptanib. It is written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets or any other suitable publication.